Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on June 23, 2025
Opus Genetics Awarded Non-Dilutive Funding from the RD Fund to Support Preclinical Development of OPGx-MERTK Program
GlobeNewswire
·
June 23, 2025
RESEARCH TRIANGLE PARK, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule …
DMC Global Announces James O’Leary is Appointed as Permanent President & CEO After Leading Company on an Interim Basis
GlobeNewswire
·
June 23, 2025
BROOMFIELD, Colo., June 23, 2025 (GLOBE NEWSWIRE) -- DMC Global Inc. (Nasdaq: BOOM) today announced that James O’Leary has agreed to serve as permanent president and CEO, in addition to his role as executive chairman. Mr. O’Leary has served as DMC’s …
EMEET Launches PIXY: The World’s First Dual-Camera AI PTZ 4K Webcam
GlobeNewswire
·
June 23, 2025
SHENZHEN, China, June 23, 2025 (GLOBE NEWSWIRE) -- EMEET, the world’s leading webcam brand, is proud to reveal PIXY, its most versatile webcam yet. PIXY is the world’s first dual-camera AI-powered PTZ (pan, tilt, zoom) 4K webcam, with features like super- …
Nano Labs Plans to Apply for License for HKD and Offshore RMB Stablecoin Businesses
GlobeNewswire
·
June 23, 2025
HONG KONG, June 23, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced that it plans to apply for relevant licenses to operate …
Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025
GlobeNewswire
·
June 23, 2025
Patients treated with CX11 (also designated as VCT220) achieved a 9.7% and 9.4% decrease in body weight from baseline after 16 weeks (p≤0.001) in the 160 mg fast and slow titration cohorts, respectively. Results suggest a favorable tolerability profile, …
Rezolve Ai to Join Russell 2000® and Russell 3000® Indices Following Breakout Year of Hypergrowth and Strategic Alliances
GlobeNewswire
·
June 23, 2025
$70 Million ARR Locked in via Customer Contracts Microsoft and Google Partnerships Accelerate Momentum NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, …
Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador
GlobeNewswire
·
June 23, 2025
Partnership supports near-term launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, June 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Annika …
FIFA, NBA, UFC and More Sports Events Go Live – Crypto Sportsbook BETY Offers Global Sports Betting Coverage 2025
GlobeNewswire
·
June 23, 2025
Paranaque City, Philippines, June 23, 2025 (GLOBE NEWSWIRE) -- Are you on the hunt for a crypto-ready sportsbook stacked with global sports and loaded with exciting bonuses? Check out BETY Sportsbook, a premium gambling site that’s focused on global sports …
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
GlobeNewswire
·
June 23, 2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment …
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
GlobeNewswire
·
June 23, 2025
Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
GlobeNewswire
·
June 23, 2025
A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“ …
Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
GlobeNewswire
·
June 23, 2025
12 of 13 participants maintained or lost weight at 3 months, with 6 of 13 losing additional weight after stopping GLP-1 therapy and undergoing Revita procedure Median weight remained stable through 3 months (0.46% / ~ 1 pound weight change within the …
New Wave Announces Non-Brokered Private Placement of Units
GlobeNewswire
·
June 23, 2025
Vancouver, BC, June 23, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp., to be renamed Humanoid Global Holdings Corp., (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it will proceed with a non-brokered private …
Fractyl Health Presents New Data at the American Diabetes Association’s 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models
GlobeNewswire
·
June 23, 2025
New findings demonstrated that a single dose of Rejuva was well tolerated in healthy animals, with no evidence of toxicity Rejuva-treated healthy animals exposed to a high fat diet were protected from weight gain and hyperglycemia Data reinforce …
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
GlobeNewswire
·
June 23, 2025
Enrollment of 51 subjects highlights significant unmet need in this serious, lifelong genetic disease which currently has no FDA-approved therapies Top-line data expected in the first quarter of 2026 WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: …
NETCLASS TECHNOLOGY INC and Nanyang Institute of Social Sciences Join Forces to Explore New Paths in Smart Education
GlobeNewswire
·
June 23, 2025
SHANGHAI and HONG KONG, June 23, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, is pleased to …
CorMedix inc. Announces Customer Implementation
GlobeNewswire
·
June 23, 2025
BERKELEY HEIGHTS, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces an update …
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
GlobeNewswire
·
June 23, 2025
Proposed reverse merger with OrthoCellix, a wholly-owned subsidiary of Ocugen, to create Nasdaq-listed, late clinical-stage regenerative cell therapy company with a first-in-class technology platform, focused on orthopedic diseases OrthoCellix is …
Quid Miner is the latest free cloud mining application, one-click mining Bitcoin (BTC), Dogecoin (DOGE), Litecoin (LTC)
GlobeNewswire
·
June 23, 2025
Lansing, Michigan, June 23, 2025 (GLOBE NEWSWIRE) -- Riding the wave of the global cryptocurrency market, Quid Miner is launching a future-oriented free cloud mining application designed to provide users with an immersive, secure and authentic experience …
Alterity Therapeutics to Provide Corporate Update in Fireside Chat
GlobeNewswire
·
June 23, 2025
MELBOURNE, Australia and SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …